[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,702
  • Shares Outstanding, K 20,225
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ 12 M
  • EBITDA $ 20 M
  • 60-Month Beta 1.30
  • Price/Sales 4.67
  • Price/Cash Flow 12.79
  • Price/Book 2.66

Options Overview Details

View History
  • Implied Volatility 30.57% (-0.22%)
  • Historical Volatility 5.16%
  • IV Percentile 3%
  • IV Rank 10.81%
  • IV High 149.14% on 01/30/26
  • IV Low 16.20% on 07/22/26
  • Expected Move (DTE 20) 0.02 (0.09%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 50
  • Volume Avg (30-Day) 235
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 2,475
  • Open Int (30-Day) 1,929
  • Expected Range 18.21 to 18.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.10
  • Growth Rate Est. (year over year) +998,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.19 +0.22%
on 07/21/26
18.50 -1.46%
on 07/01/26
-0.08 (-0.44%)
since 06/30/26
3-Month
13.21 +38.00%
on 05/15/26
18.68 -2.41%
on 06/30/26
+4.06 (+28.65%)
since 04/30/26
52-Week
11.09 +64.38%
on 03/30/26
21.01 -13.23%
on 01/23/26
+5.17 (+39.59%)
since 07/30/25

Most Recent Stories

More News
Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

APGE : 134.09 (-0.16%)
SLP : 18.23 (-0.38%)
DSGR : 34.57 (+0.03%)
AVB : 185.61 (-1.16%)
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Simulations Plus ...

SLP : 18.23 (-0.38%)
Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws

San Diego, California--(Newsfile Corp. - July 29, 2026) - Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated...

SLP : 18.23 (-0.38%)
SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO , July 28, 2026 /PRNewswire/ -- Robbins LLP  announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities...

SLP : 18.23 (-0.38%)
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation

Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities laws or breached fiduciary duties owed...

SLP : 18.23 (-0.38%)
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG

NEW YORK , July 23, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

PASG : 4.47 (-0.45%)
CRNX : 83.52 (-0.13%)
SLP : 18.23 (-0.38%)
NCSM : 47.00 (+3.48%)
Simulations Plus Reports Profitability Rebound Ahead of Altaris Acquisition Close

Barchart Research What to Expect from SLP Earnings SLP Generated July 10, 2026 Current Price $18.24 Consensus Rating Hold Average Move 10.96% Simulations Plus Reports Profitability Rebound Ahead of Altaris...

SLP : 18.23 (-0.38%)
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN

NEW YORK , July 10, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

HUN : 9.76 (-19.14%)
OLN : 18.51 (-16.51%)
PULM : 1.7400 (+2.35%)
SLP : 18.23 (-0.38%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

Simulations Plus: Fiscal Q3 Earnings Snapshot

SLP : 18.23 (-0.38%)
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported...

SLP : 18.23 (-0.38%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 18.43
2nd Resistance Point 18.38
1st Resistance Point 18.31
Last Price 18.23
1st Support Level 18.19
2nd Support Level 18.14
3rd Support Level 18.07

See More

52-Week High 21.01
Last Price 18.23
Fibonacci 61.8% 17.22
Fibonacci 50% 16.05
Fibonacci 38.2% 14.88
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.